Clinical Trials Browser

Phase 2/3 × OTHER × Radiotherapy × Clear all

NCT05050162 2026-04-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase 2/3 Suspended

Carcinoma, Oropharyngeal Neoplasms

NCT07353671 2026-03-25

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Phase 2/3 Recruiting

Head and Neck Neoplasms, Radiodermatitis

NCT06282588 2026-03-19

THUNDER

Phase 2/3 Recruiting

Prostatic Neoplasms

NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Phase 2/3 Active not recruiting

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT07076693 2025-07-22

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07000253 2025-06-02

OMEC-5

Phase 2/3 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06907602 2025-04-02

ONTRESCC

Phase 2/3 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02945566 2025-03-27

STAR-TREC

Phase 2/3 Active not recruiting

Gastrointestinal

Rectal Neoplasms

NCT06758830 2025-01-09

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2/3 Recruiting

Gastrointestinal

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

NCT03600831 2024-01-09

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

Phase 2/3 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01666808 2023-08-02

FACBC Outcomes for Post Prostatectomy

Phase 2/3 Completed

165 enrolled 22 charts

Prostatic Neoplasms

NCT00096460 2023-01-05

BMT CTN 0202

Phase 2/3 Terminated

30 enrolled 5 charts

Lymphoma, Follicular

NCT05433597 2022-06-27

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

Phase 2/3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT05144100 2021-12-03

SCOPE

Phase 2/3 Not yet recruiting

Carcinoma

NCT04138992 2020-06-30

A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

Phase 2/3 Unknown

Disease Free Survival

NCT04105374 2020-03-24

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase 2/3 Withdrawn

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT04244708 2020-01-28

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Phase 2/3 Unknown

Pituitary Neoplasms

NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Phase 2/3 Unknown

Non Small Cell Lung Cancer Metastatic

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00784537 2018-02-08

HD0801

Phase 2/3 Completed

Hodgkin Disease

NCT03344068 2017-12-22

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

Phase 2/3 Unknown

Nasopharyngeal Carcinoma

NCT01434394 2017-08-21

EAGLE

Phase 2/3 Completed

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01542931 2017-08-21

TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Phase 2/3 Completed

Squamous Cell Carcinoma of Head and Neck

NCT00002533 2016-12-15

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Phase 2/3 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Infections, Esthesioneuroblastoma, Olfactory

NCT00861094 2015-12-18

Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01937650 2013-09-09

Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda

Phase 2/3 Completed

Uterine Cervical Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Phase 2/3 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01064999 2012-03-14

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Phase 2/3 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01402180 2011-07-26

Nimotuzumab

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00003187 2010-02-24

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Phase 2/3 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma